Schwab Charles CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, sold 46,410 shares of common stock on August 12, 2026 for $108.18 per share.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, sold 46,445 shares of common stock on August 11, 2026 for $107.78 per share.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, reported a transaction in 37,200 shares of common stock on August 6, 2026.
NYSE
Nigel J Murtagh, Chief Risk Officer of Schwab Charles Corp, sold 26,675 shares of common stock on August 6, 2026.
NYSE
Paula A Sneed, a Director of Schwab Charles Corp, sold 5,263 shares of common stock on August 7, 2026 for $107.15 per share.
NYSE
Carolyn Schwab-Pomerantz, a Director of Schwab Charles Corp, sold 18,561 shares of common stock on August 5, 2026 for $107.70 per share.
NYSE
Jonathan M. Craig, MD, Head of Retail Investing of Schwab Charles Corp, sold 21,750 shares of common stock on August 5, 2026 for $107.02 per share.
NYSE
Carolyn Schwab-Pomerantz, a Director of Schwab Charles Corp, sold 22,640 shares of common stock on August 4, 2026 for $106.36 per share.
NYSE
Dennis Howard, MD, Chief Tech, OPS & Data Off of Schwab Charles Corp, reported a transaction in 1,292 shares of common stock on August 1, 2026.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, sold 142,900 shares of common stock on August 3, 2026.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, sold 143,450 shares of common stock on July 28, 2026.
NYSE
Carolyn Schwab-Pomerantz, a Director of Schwab Charles Corp, sold 22,650 shares of common stock on July 28, 2026 for $105.71 per share.
NYSE
Dennis Howard, MD, Chief Tech, OPS & Data Off of Schwab Charles Corp, sold 28,000 shares of common stock on July 28, 2026 for $105.01 per share.
NYSE
Walter W Bettinger, Co-Chairman and a Director of Schwab Charles Corp, sold 285,896 shares of common stock on July 27, 2026.
NYSE
Nigel J Murtagh, Chief Risk Officer of Schwab Charles Corp, sold 32,947 shares of common stock on July 27, 2026.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, sold 45,500 shares of common stock on July 24, 2026 for $101.72 per share.
NYSE
Peter J. Morgan Iii, General Counsel of Schwab Charles Corp, sold 6,952 shares of common stock on July 23, 2026 for $102.03 per share.
NYSE
Nigel J Murtagh, Chief Risk Officer of Schwab Charles Corp, sold 4,053 shares of common stock on July 21, 2026 for $104.14 per share.
NYSE
Jonathan S Beatty, MD, Head of Advisor Services of Schwab Charles Corp, sold 2,000 shares of common stock on July 21, 2026 for $104.21 per share.
NYSE
Charles Schwab Corp. executive Jonathan M. Craig reported the sale of 21,750 shares of common stock, executed under a pre-arranged 10b5-1 trading plan.
NYSE
Jonathan S. Beatty, MD, Head of Advisor Services at Charles Schwab Corp., reported the sale of 2,000 shares of common stock for $102.00 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
Stephen Ellis, a Director at Charles Schwab Corp., acquired restricted stock units (RSUs) on July 1, 2026, as part of the Directors' Deferred Compensation Plan.
NYSE
Frank C. Herringer, a Director at Charles Schwab Corp., received 457 Restricted Stock Units (RSUs) on July 1, 2026, as part of the Directors' Deferred Compensation Plan II.
NYSE
Director Charles Ruffel acquired 1,280 non-qualified stock options for Charles Schwab Corp. (SCHW) under a deferred compensation plan.
NYSE
Director Marianne Catherine Brown acquired restricted stock units in Charles Schwab Corp. (SCHW) on July 1, 2026, as part of the Directors' Deferred Compensation Plan II.
NYSE
Jonathan S. Beatty, MD, Head of Advisor Services at Charles Schwab Corp., reported transactions involving the sale of company stock under a pre-arranged trading plan.
NYSE
Stephen Ellis, a Director at Charles Schwab Corp., reported a transaction involving the acquisition of 2,258 shares of common stock.
NYSE
Charles Schwab CFO Michael D. Verdeschi disposed of 6,519 shares of common stock to satisfy tax withholding obligations related to restricted stock unit vesting.
NYSE
Charles Schwab Corporation director John K. Adams Jr. was granted 1,602 restricted stock units and 3,977 stock options.
NYSE
Director Charles A. Ruffel was granted 1,602 restricted stock units and 3,977 stock options under the 2022 Stock Incentive Plan.